Preclinical studies of 166 Ho-chitosan for treatment of hepatocellular carcinoma

@inproceedings{Yousefnia2015PreclinicalSO,
  title={Preclinical studies of 166 Ho-chitosan for treatment of hepatocellular carcinoma},
  author={Hassan Yousefnia and Ahmad Bitarafan-Rajabi and Mir sepehr Pedram and Samaneh Zolghadri and Ali Bahrami-Samani and Amir Reza Jalilian and Mohammad Sh. Mazidi and Amir Darbandi Azad and Mohammad Ghannadi-Maragheh},
  year={2015}
}
Introduction: Recently, due to the special characteristics of Ho and chitosan, Ho-chitosan complex was developed for treatment of tumors such as hepatocellular carcinoma. This complex has been lately prepared with high radiochemical purity in our lab. The preclinical studies of the complex however should be performed to evaluate the tracer concentration in target and normal tissues before human use. Methods: In this study, Ho-chitosan was prepared and its preclinical studies for treatment of… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-10 OF 14 REFERENCES

Biodistribution and kinetics of holmium-166-chitosan complex (DW-166HC) in rats and mice.

  • Journal of nuclear medicine : official publication, Society of Nuclear Medicine
  • 1998
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

The role of preclinical models in radiopharmaceutical therapy.

  • American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
  • 2014
VIEW 1 EXCERPT

Radionuclide therapy of hepatocellular carcinoma

  • Biomedical imaging and intervention journal
  • 2003
VIEW 1 EXCERPT

Similar Papers

Loading similar papers…